Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial - Kubasch, Anne Sophie; Peterlin, P.; Cluzeau, T.; Götze, K. S.; Sockel, K.; Teipel, R.; Jentzsch, M.; Attalah, H.; Sebert, M.; Chermat, F.; Gloaguen, S.; Puttrich, M.; et al. (Leukemia, 2023)
Online veröffentlicht: 21. September 2023